Home > Insider Trading > Filing (0001179110-15-005348)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070081	Ptc Therapeutics Inc.	PTCT	Pharmaceutical Preparations (2834)	043416587

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1578852	Elliott Mark Boulding	C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080	Exec. Vp And Clo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2015-03-20	13,453	$67.77	18,782	No	4	S	Direct
Common Stock	Disposition	2015-03-20	7,547	$68.72	11,235	No	4	S	Direct
Common Stock	Disposition	2015-03-20	142	$69.77	11,093	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sale transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on August 11, 2014 for the primary purposes of covering tax obligations associated with a restricted stock vesting event and diversification.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $67.31 to $68.28 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $68.31 to $69.26 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.